Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with aG551DMutation-Reference-Cited by-同舟云学术

Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with aG551DMutation

Published:2013-06 Issue:11 Volume:187 Page:1219-1225
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Davies Jane C.,Wainwright Claire E.,Canny Gerard J.,Chilvers Mark A.,Howenstine Michelle S.,Munck Anne,Mainz Jochen G.,Rodriguez Sally,Li Haihong,Yen Karl,Ordoñez Claudia L.,Ahrens Richard

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference24 articles.

1. Cystic Fibrosis Foundation. Cystic fibrosis foundation patient registry: 2010 annual data report. Bethesda, MD: Cystic Fibrosis Foundation; 2011.

2. The prevalence of cystic fibrosis in the European Union

3. Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis

4. Identification of the Cystic Fibrosis Gene: Genetic Analysis

5. Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA

Cited by 446 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Retrospective, Longitudinal Registry Study on the Long-Term Durability of Ivacaftor Treatment in People with Cystic Fibrosis;Pulmonary Therapy;2024-09-12

2. Advances in Care and Outcomes for Children with Cystic Fibrosis;Clinics in Chest Medicine;2024-09

3. A rapid LC-MS/MS method for the simultaneous quantification of ivacaftor, lumacaftor, elexacaftor, tezacaftor, hexyl-methyl ivacaftor and ivacaftor carboxylate in human plasma;Journal of Pharmaceutical and Biomedical Analysis;2024-09

4. Improving growth in infants with CF;Pediatric Pulmonology;2024-08-06

5. Nutritional status in the era of highly effective CFTR modulators;Pediatric Pulmonology;2024-08-06